Total Payments
$752.42
2024 Payments
$185.30
Companies
13
Transactions
34
Medicare Patients
928
Medicare Billing
$93,994
Payment Breakdown by Category
Food & Beverage$752.42 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $752.42 | 34 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $173.32 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $157.41 | 3 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $99.99 | 1 | $0 (2019) |
| Novo Nordisk Inc | $77.14 | 5 | $0 (2024) |
| Lilly USA, LLC | $58.38 | 4 | $0 (2024) |
| Abbott Laboratories | $44.51 | 2 | $0 (2024) |
| Genentech USA, Inc. | $32.42 | 2 | $0 (2020) |
| GlaxoSmithKline, LLC. | $28.23 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $27.47 | 2 | $0 (2024) |
| Shield Therapeutics Inc | $14.10 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $185.30 | 10 | ABBVIE INC. ($66.38) |
| 2023 | $124.75 | 8 | AbbVie Inc. ($53.78) |
| 2022 | $118.86 | 8 | ABBVIE INC. ($30.58) |
| 2021 | $69.26 | 4 | Novo Nordisk Inc ($31.39) |
| 2020 | $139.60 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($121.84) |
| 2019 | $114.65 | 2 | Teva Pharmaceuticals USA, Inc. ($99.99) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Diabetes Care | ||||||
| 09/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Hepatitis B Vaccine | ||||||
| 07/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Diabetes Care | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Hematology | ||||||
| 10/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Obesity | ||||||
| 06/27/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: VACCINES | ||||||
| 02/28/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Gastroenterology | ||||||
| 11/07/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 09/27/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: Obesity | ||||||
| 09/14/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Neuroscience | ||||||
| 07/12/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $13.52 | General |
| Category: Pain Management | ||||||
| 06/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 398 | 545 | $73,562 | $38,669 |
| 2022 | 10 | 462 | 671 | $84,158 | $47,104 |
| 2021 | 3 | 68 | 86 | $13,064 | $8,221 |
Total Patients
928
Total Services
1,302
Medicare Billing
$93,994
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 202 | $29,896 | $16,530 | 55.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 62 | 62 | $14,198 | $7,596 | 53.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 89 | $9,434 | $4,974 | 52.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 17 | $6,749 | $3,549 | 52.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $4,122 | $1,882 | 45.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $2,520 | $1,516 | 60.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 12 | 26 | $3,960 | $1,178 | 29.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $792.00 | $704.64 | 89.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 54 | $1,026 | $514.08 | 50.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 20 | $800.00 | $180.37 | 22.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 13 | $65.00 | $44.33 | 68.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 284 | $42,032 | $23,507 | 55.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 155 | $16,430 | $9,504 | 57.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $10,534 | $5,772 | 54.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 12 | $4,764 | $2,370 | 49.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $4,200 | $2,263 | 53.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 24 | 24 | $2,400 | $1,686 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 30 | $990.00 | $840.21 | 84.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 38 | 64 | $1,216 | $612.38 | 50.4% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 13 | 19 | $1,482 | $473.66 | 32.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 22 | $110.00 | $75.67 | 68.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 53 | $7,844 | $5,158 | 65.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 14 | 14 | $3,206 | $1,801 | 56.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 19 | $2,014 | $1,262 | 62.7% |
About Dr. Samantha Carson, DO
Dr. Samantha Carson, DO is a Family Medicine healthcare provider based in Fostoria, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2018. The National Provider Identifier (NPI) number assigned to this provider is 1710484639.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samantha Carson, DO has received a total of $752.42 in payments from pharmaceutical and medical device companies, with $185.30 received in 2024. These payments were reported across 34 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($752.42).
As a Medicare-enrolled provider, Carson has provided services to 928 Medicare beneficiaries, totaling 1,302 services with total Medicare billing of $93,994. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Fostoria, OH
- Active Since 04/08/2018
- Last Updated 11/03/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1710484639
Products in Payments
- JARDIANCE (Drug) $157.31
- VRAYLAR (Drug) $103.40
- AJOVY (Drug) $99.99
- UBRELVY (Drug) $54.71
- FREESTYLE LIBRE 3 (Device) $44.51
- Ozempic (Drug) $34.29
- Xofluza (Drug) $32.42
- MOUNJARO (Drug) $31.14
- FARXIGA (Drug) $27.47
- OFEV (Drug) $15.29
- QULIPTA (Drug) $15.21
- Wegovy (Drug) $15.13
- TRELEGY ELLIPTA (Drug) $14.55
- ACCRUFER (Drug) $14.10
- SHINGRIX (Biological) $13.68
- Seglentis (Drug) $13.52
- XIFAXAN (Drug) $13.37
- Saxenda (Drug) $12.68
- Heplisav-B (Drug) $12.56
- EMGALITY (Drug) $12.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fostoria
Dr. Jill Badik, Do, DO
Family Medicine — Payments: $1,788
Family Medicine $1,788
Dr. Michael Badik, Do, DO
Family Medicine — Payments: $1,128
Family Medicine $1,128
Mr. Tim Beidelschies, Md, MD
Family Medicine — Payments: $92.70
Family Medicine $92.70
Alisa Ingram, Md, MD
Family Medicine
Family Medicine
Dr. Pramuan Thirasilpa, Md, MD
Family Medicine
Family Medicine
Edwin Davis, Md, MD
Family Medicine
Family Medicine